Newsflow

I rang the company a few times today and finally got through just before close of trading. Spoke to one of the directors and put forward some of the questions being asked here, particularly around lack of clarity on whether HCT's lab tests were the ones the boss mentioned on the video, and suggested strongly that we shareholders were feeling very uninformed on progress etc. He stated that our tests were being done separately to HCT's, possibly in a different lab and that the market would be updated as soon as results were known. He did not comment on the relevance of HCT's results. So I feel somewhat reassured that today's debacle may soon be resolved with the release of results directly relating to SKN's product.